Ranked list
The 10 largest medical groups in Arizona by Medicare Part B payments
The same ranking for Arizona medical groups.
UNM Medical Group, Inc. has the most Medicare Part B payments of any medical group in New Mexico, $71.3 million, followed by Presbyterian Medical Group in Albuquerque ($69.5M) and Rehoboth McKinley Christian Health Care Services in Gallup ($38.6M). Together the 10 leaders account for $401.3 million in Medicare Part B payments in three cities.
The 10 highest of 598 New Mexico medical groups that report Medicare Part B payments. Ranks compare size, not quality of care.
Every medical group in New Mexico598 New Mexico medical groups report Medicare Part B payments, $968.6 million in all. The 10 on this list hold $401.3 million of it. The median medical group has $144,626 in Medicare Part B payments, so UNM Medical Group, Inc. is about 493 times that size.
FAQ
Answers from the same data, updated monthly.
UNM Medical Group, Inc. in Albuquerque, with $71.3 million in Medicare Part B payments. Presbyterian Medical Group is second with $69.5M.
UNM Medical Group, Inc. ($71.3M), Presbyterian Medical Group ($69.5M), Rehoboth McKinley Christian Health Care Services ($38.6M), Eye Associates of New Mexico ($37.3M), Gerald Champion Regional Medical Center ($35.8M), Lovelace Medical Center, Interventional Radiology ($33.8M), New Mexico Cancer Center (NMCC) ($33.4M), Lovelace Medical Group ($33.3M), High Desert Nephrology Associates ($28.1M), Gallup Indian Medical Center ($20.2M).
The median New Mexico medical group that reports Medicare Part B payments has $144,626 in Medicare Part B payments, out of 598 that report them.
Every month, when the Dmand AI database refreshes. This version is from Oct 28, 2026.
Ranked list
The same ranking for Arizona medical groups.
Ranked list
The national ranking by Medicare Part B payments.
Dmand AI
Reach the buying committee at the 10 top New Mexico medical groups
Pick a medical group from this list and see its leaders by department, with direct dials and email, in one login.